Latebreakers: Which inhalers are nonessential and hurt the environment?

Can metered-dose inhalers containing flunisolide, triamcinolone, metaproterenol, pirbuterol, albuterol and ipratropium in combination, cromolyn, and nedocromil be phased out because they harbor ozone-depleting substances? If there are alternate products that provide the same benefits as these drugs, they are nonessential and can be removed from the market by, say, Dec. 31, 2009, after a transition period. So proposed the FDA in the June 11 Federal Register. The agency said it would hold a public meeting to discuss this matter. For now, please send your comments to the FDA by Aug. 10. (For more on inhalers and the ozone layer.)